Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -417.55 Million USD | -4.28% |
| 2022 | -400.43 Million USD | 14.6% |
| 2021 | -468.9 Million USD | -128.26% |
| 2020 | -205.42 Million USD | -249.88% |
| 2019 | 137.06 Million USD | -40.81% |
| 2018 | 231.55 Million USD | 155.42% |
| 2017 | -417.77 Million USD | -3.02% |
| 2016 | -405.53 Million USD | 1.75% |
| 2015 | -412.77 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -484.76 Million USD | 4.16% |
| 2024 Q1 | -487.91 Million USD | -16.85% |
| 2023 Q2 | -321.55 Million USD | 1.5% |
| 2023 Q3 | -389.8 Million USD | -21.23% |
| 2023 Q4 | -417.55 Million USD | -7.12% |
| 2023 Q1 | -326.45 Million USD | 18.47% |
| 2023 FY | -417.55 Million USD | -4.28% |
| 2022 Q2 | -442.39 Million USD | 0.0% |
| 2022 FY | -400.43 Million USD | 14.6% |
| 2022 Q4 | -400.43 Million USD | -13.85% |
| 2022 Q3 | -351.72 Million USD | 20.49% |
| 2021 Q2 | -384.94 Million USD | 0.0% |
| 2021 FY | -468.9 Million USD | -128.26% |
| 2021 Q4 | -458.06 Million USD | 0.0% |
| 2020 FY | -205.42 Million USD | -249.88% |
| 2020 Q4 | -234.48 Million USD | 0.0% |
| 2019 Q2 | 282.45 Million USD | 0.0% |
| 2019 Q4 | 186.17 Million USD | 0.0% |
| 2019 FY | 137.06 Million USD | -40.81% |
| 2018 FY | 231.55 Million USD | 155.42% |
| 2018 Q4 | 231.55 Million USD | 0.0% |
| 2017 FY | -417.77 Million USD | -3.02% |
| 2016 FY | -405.53 Million USD | 1.75% |
| 2015 FY | -412.77 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 87157.393% |
| Ansell Limited | -54.99 Million USD | -659.233% |
| Ansell Limited | -55.1 Million USD | -657.812% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | -1044.198% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -397184.778% |
| Psykey, Inc. | 634.59 Thousand USD | 65898.748% |
| ConvaTec Group Plc | 1.2 Billion USD | 134.779% |
| ConvaTec Group Plc | 1.2 Billion USD | 134.73% |
| Encision Inc. | 1.29 Million USD | 32451.167% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 18185.987% |
| Innovative MedTech Inc. | 1.76 Million USD | 23761.004% |
| LifePoint, Inc. | -3.26 Million USD | -12692.634% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 8614.249% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 19413.332% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -964139.44% |
| Reflect Scientific, Inc. | -1.03 Million USD | -40231.442% |
| SmileDirectClub, Inc. | 778.67 Million USD | 153.624% |
| Sector 10, Inc. | 163 Thousand USD | 256268.25% |
| SheerVision, Inc. | 57.34 Thousand USD | 728193.336% |
| United Health Products, Inc. | 660.56 Thousand USD | 63311.299% |
| Vasamed, Inc. | 22.12 Thousand USD | 1887606.767% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 15969.232% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 54167.798% |